characteristics of patient transfer between spoke and hub are poorly understood.
C urrent models of acute stroke care have been designed to ensure rapid delivery of intravenous tissue-type plasminogen activator (tPA) to all eligible patients. Telestroke, the remote use of audio/video conferencing to assist with care decisions for patients presenting to environments with limited resources, is a highly effective method of improving stroke care delivery and increasing tPA utilization. 1, 2 The hub-andspoke model, where a large tertiary care center serves as the hub for smaller community spoke hospitals, is widely practiced and is the model used at our center. 3 Although present telestroke models are safe and efficient in administering tPA to eligible patients, a prominent concern has been time delays to the delivery of endovascular thrombectomy (ET). Given the benefit of ET for patients with strokes secondary to large vessel occlusions (LVO), 4 developing systems of care that effectively transport such patients from telestroke spokes to ET-capable centers is essential. 5, 6 Although there are growing data to help determine how to triage patients that require transport to a hub capable of ET,
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Methods

Study Setting
This study was Institutional Review Board approved and Health Insurance Portability and Accountability Act compliant and is a retrospective cohort study of prospectively acquired data. The authors declare that all supporting data are available within the article and in the online-only Data Supplement. We evaluated consecutive patients transferred from spoke hospitals to our hub hospital, utilizing data from the local Get With The Guidelines-Stroke registry, institutional telestroke logs, and the institutional ET database. Get With The Guidelines-Stroke registry is a voluntary, continuous registry, and performance improvement initiative. 8 Ninety-day modified Rankin Scale (mRS) data were collected prospectively on patients who underwent ET.
The hub-and-spoke telestroke network is composed of 40 spoke hospitals; hospitals transferred patients by either ground ambulance or helicopter ( Figure I in the online-only Data Supplement). The hub is located in a city of 650 000 people, with a population density of 13 000 per square mile in 2015. However, the wider functional metropolitan area based on commuting patterns is 8.2 million.
9 Within our institutional Get With The Guidelines-Stroke registry, we identified all ischemic stroke patients who were transferred to our hub center from January 2011 to October 2015 and identified as potential ET candidates at the time of transfer initiation ( Figure 1 ). This was determined by selecting those with National Institutes of Health Stroke Scale (NIHSS) >6 and last known well <12 hours by hub arrival (n=618). For patients who meet these criteria, our protocol is established such that the goal of transfer is always presumed ET evaluation. Of these 618 patients, 325 had digital computed tomography (CT) images available for review at the spoke hospital to determine Alberta Stroke Program Early CT Score (ASPECTS), which was calculated by 2 independent raters (Drs Boulouis and Lauer). At the time of this study, our telestroke system discouraged CT angiography or additional more advanced imaging at the spoke hospital as it would have been repeated at the hub, per protocol. Of these 325 patients, 234 were transferred after telestroke consult. Of the 234, 114 were transferred by helicopter, and 120 were transferred by ground ambulance. Sixty-three were treated with ET, and 90-day mRS was available for 53.
Key Variables
Actual transfer time was defined as the time from initiation of the telestroke consult response (derived from the telestroke log) to arrival at the hub (emergency room triage data derived from Get With The Guidelines-Stroke registry). Ideal transfer time was calculated using Google Maps (Mountain View, CA), correcting for both date and time to account for traffic for ground ambulance transfers and calculated using straight-line distance for helicopter transfers. For ground ambulance transfers, 60 minutes was added to the average driving time to account for the telestroke consult time, treatment and stabilization of the patient, and preparation of the patient for transport. 10 For helicopter transfers, the straight-line distance was divided by 3.5 km/min, the average helicopter speed. 11 To this value, 75 minutes was added to account for the increased dispatch time of helicopter transport 12 and patient processing. Ideal time was subtracted from actual time to calculate delay. Weather Underground (San Francisco, CA), which utilizes data from the National Weather Service, was used to collect historical weather data based on date and time of transport to the hub.
Statistical Analyses
Lilliefors test was used to assess normality on noncategorical variables. Median and interquartile range were reported for continuous variables. Percent and count were reported for categorical variables. Differences were assessed using nonparametric Wilcoxon rank-sum for continuous variables and χ 2 tests for categorical variables. A binary logistic regression model was fit to investigate the association between transfer time and the probability of undergoing ET. Linear regression models were fit to investigate the association between transfer time and either change in ASPECTS or 90-day mRS. A multivariable regression model was fit to explore 3 possible predictors of delay (night versus day, weekend versus weekday, tPA delivery at spoke). Spearman correlation was used to assess the relationship between distance and transfer time. P values <0.05 for 2-sided tests were interpreted as statistically significant. Parameter estimates (β) and correlation coefficients (ρ) were reported where appropriate. Analyses were performed with SPSS version 21.0 (IBM Corp) and Matlab R2015a Statistics Toolbox (Mathworks, Inc).
Results
In our sample of 234 patients, median age was 72 years, 54% were male, and 85% were white. Helicopter was used for 49% of transfers, ground ambulance for 51%. Patient demographic and past medical history were similar for those transferred by ground and by helicopter ( Table 1) . In a year-to-year comparison from January 2011 to October 2015, 23 patients were transferred in 2011, 56 patients in 2012, 43 patients in 2013, 62 patients in 2014, and 50 patients in 2015. The median measured actual transfer time was 132 minutes; median calculated ideal transfer time was 102 minutes, with a median calculated delay of 25 minutes ( Table 2 ). The median last known well at the time of hub arrival was 4.6 hours. The median road distance from spoke to the hub was 86 km, and median straightline distance was 74 km. Twenty-eight percent of transfers occurred on weekends, and 52% occurred at night (18:00 to 06:00 hours).
Median NIHSS was 15 at spoke hospitals, with a median NIHSS improvement of 2 during transfer. Median ASPECTS was 10 at spoke hospitals, with a median decrease of 2 (Table 3) . On arrival to the hub, 91% of patients had hemiparesis and 71% had aphasia. Intravenous tPA was administered to 67% of patients while at the spoke hospital (Table 2) . ET was performed on 27% of transferred patients at the hub ( Table 3) . Of all transferred patients, symptomatic intracranial hemorrhage occurred in 7% and treatment was withdrawn by family in 21% during hospitalization. Median mRS at the time of discharge was 4, with 24% of patients discharged home. Of the patients who underwent ET, 36% achieved mRS 0 to 2 and median mRS was 4 at 90 days (Table 3) .
Longer transfer time was associated with decreased odds of undergoing ET in logistic regression (odds ratio, 0.990; 95% confidence interval, 0.983-0.997; P=0.004; Table 4 ). The probability of ET after a transfer time of 60 minutes is 0.44. This probability decreases by 1% for each additional minute of transfer time. Median transfer time was significantly shorter among those that underwent ET versus those that did not (124 versus 138 minutes, interquartile range, 93-104 versus 107-174; P=0.004). In linear regression, transfer time was not significantly associated with ASPECTS decrease during transfer (n=200, β=0, P=0.961). Furthermore, for those patients undergoing ET, transfer times were not associated with functional outcomes as measured by 90-day mRS (n=53, β=0.005, P=0.480).
Associations between delay in transfer and time of transfer (night or day), day of transfer (weekend or weekday), and tPA administration were explored using a multivariable regression model (Table 4) . Overall, the model explained a significant amount of variance (n=234, R 2 =0.078, P<0.0005). Nocturnal transfer was associated with significantly longer delay in transfer (β=20.5, P<0.0005), with an additional 20.5 minutes delay associated with a transfer at night. The median delay for nocturnal transfer was 31 minutes (interquartile range, 11-51), compared with a daytime transfer at 14 minutes (interquartile range, −9 to 36). However, neither weekend (β=8.3, P=0.145), nor intravenous tPA delivery at spoke hospital (β=6.3, P=0.248) contributed significantly to the model variance. We also examined predictors of delay stratified separately by helicopter and ground transport. Our findings were unchanged (Table I in the online-only Data Supplement).
Helicopter transfers had longer median road (97 versus 69 km) and median straight-line (83 versus 55 km; Table 2 ) distances compared with ground transfers. There was no difference in wind speed comparing helicopter and ground transfers. However, there were significantly more patients transferred by ground when visibility was <16 km (Table 2) .
There was a significant association between longer transfer time and both greater road distance (ρ=0.484, P<0.0005) and greater straight-line distance (ρ=0.497, P<0.0005) between hospitals. In calculating delay, we controlled for this using the calculated ideal transfer time. Actual transfer time was better than ideal transfer time (ie, negative delay) for 23% of patients, of whom 58% were ground transfers. In a sensitivity analysis, multivariable regression models were fit to test the associations between the time of transfer, the day of transfer, and tPA administration with the delay in transfer. An additional covariate (straight distance or driving distance) was added to account for remaining variability in ideal transfer time that may not be accounted for by our estimate. These models continued to show a significant effect of day/night transfer time on transfer delay (Table II in 
Discussion
In this analysis of data from a hub-and-spoke academic telestroke network, we found that potential LVO stroke patients with longer transfer times had lower odds of undergoing ET. This probability decreases by 1% for each additional minute of transfer time >60 minutes. Patients undergoing ET after the transfer had a median transfer time of 124 minutes, compared with a median transfer time of 138 minutes for patients who did not. A similar finding was demonstrated in a Chicago-based study, where the odds of ET decreased by 2.5% for every minute of transfer time. 13 Additionally, in our data nocturnal transfers were associated with a substantial delay relative to daytime transfers, highlighting the recognized impact of care discrepancies during night hours and the potential impact on outcome. 14 Rapid care delivery for LVO patients is a healthcare priority given the impact of time on ET outcomes. 15 Because the majority of patients first present to local hospitals and require transfer to ET-capable facilities, 16 it is crucial to evaluate and refine the process of transfer. Applying metrics and protocols for transfer, especially at There were no significant differences comparing ground to helicopter except for ASPECTS decrease (*P=0.0495). ASPECTS indicates Alberta Stroke Program Early CT Score; CT, computed tomography; ET, endovascular thrombectomy; ICH, intracranial hemorrhage; IQR, interquartile range; mRS, modified Rankin Scale; N, sample size; and NIHSS, National Institutes of Health Stroke Scale. night, will likely have a positive impact on transfer times and subsequently patient outcomes.
Efforts to speed transit to the nearest ET-capable center include choice of transport mode. In one system, helicopter provides the fastest means for distances over 10 miles.
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Despite the cost of such transport, the benefit in time saved and disability spared makes this a cost-effective transport option for treatment. 17 Consistent with this, we found helicopter utilized more frequently for transfer of patients from greater distances (Table 2; Figure I in the online-only Data Supplement). Our calculations factor in the time cost of geography, by accounting for vehicular ground or airspeed. No additional statistical differences comparing helicopter to ground ambulance for transfer delays were found. Further, the impact of weather was limited, despite flight restrictions in bad weather (as evidenced by reduced flights during conditions of poor visibility). Regional emergency transport services operate under strict protocols and frequent quality control, which likely explains the consistency of this result.
Beyond fundamental telestroke hub-and-spoke models there is renewed focus on certification for centers that treat stroke. Traditional procedural quality standards are increasingly being associated with time-based metrics. 18, 19 Using such metrics to improve both spoke and hub hospital emergency room workflow is a major focus of expediting ET. However, activation or mobilization time for transfer from various geographies is an additional source of delay and presents a challenge to benchmark. We controlled for this using an algorithm based on existing data about mobilization for transport. [10] [11] [12] We propose separate air and ground algorithms that factor in activation time, geographic distance, and typical speeds (Figure 2 ) to allow target time metrics customized for each center within a referral network. Formulation of target transfer times will allow metrics to encompass the entire transfer process, not just the emergency room process at the spoke hospital, and further aid in evaluating areas of potential quality improvement.
The present sample was selected on the basis of last seen well and NIHSS, providing a clinical suspicion for ET candidacy. Median NIHSS was 15 at transfer, supporting the presumption that the sample reflects mostly LVO patients, further supported by the high percentage of patients with cortical signs. 20 Despite patients presenting with high NIHSS, last seen well <6 hours, and ASPECTS >6, only 27% of patients in our study underwent ET. For these patients, there was no association between transfer time and 90-day mRS. Considering advanced imaging selection at time of presentation this is not surprising. Patients are relatively standardized by candidacy for ET, irrespective of time from onset, and the more selective the institutional protocol the more standardized the treated sample. Our protocol specifically targets the presence of LVO with limited infarct core volume for treatment inclusion. 21 Many transferred patients are not candidates for intervention. Our 27% treated with ET is lower than another similar study. 13 However, intravenous tPA was given to more patients (67%) in our sample, and hence the resolution of LVO because of thrombolysis may be a contributor. Another contributor is the exclusion of patients with large core infarcts given the use of magnetic resonance imaging selection. 21 The importance of this exclusion criteria for LVO patients in early timeframes remains uncertain. Several recent trials [22] [23] [24] have demonstrated treatment benefit with selectivity limited to identification of LVO and onset within 6 hours of groin access, ambivalent to infarct core. That data expanded our institutional approach from October 2015. Selection for treatment can also occur at the spoke hospital level, with recent efforts demonstrating a positive impact on a patient selection from CT angiography triage at the spoke hospital. 7 Although refining LVO detection and selection at both hub-and-spoke will be a crucial step in the next iteration of stroke care, it remains independent of the speed and efficacy of transfer.
There was no association between longer transfer time and ASPECTS decrease, confirming a previous finding. 6 Additionally, delivery of tPA at the spoke hospital was not associated with transfer delay in this study, underscoring the impact of effective protocols in place, a particular focus of telestroke network efforts. 1, 2 Although there likely exists a distance around the hub for each telestroke network where direct triage is more appropriate, 25, 26 this support the argument for tPA delivery to all eligible ET candidates if a patient presents first to a spoke hospital without ET capabilities.
Not all patients suffer equally from the impact of transfer delays. Recent results from DAWN and DEFUSE 3 support Algorithms for target transfer times for both helicopter and ground transfers. Airspeed was assigned a constant value of 3.5 km/min (average medical helicopter airspeed), ground speed was individualized, retrospectively calculated using Google Maps specific for the date and time of each transfer. For metric purposes, a single averaged value could be applied.
the value of imaging selection in late time windows, selecting for small core infarct and significant clinical deficit. 27, 28 It is anticipated that this will increase the total number of patients evaluated for ET, providing access to therapy to a potentially far larger population. However, although a subset of patients will sustain ischemic penumbra into late time windows, 5 this has a little practical impact on transfer expectations. For all patients with unknown vessel occlusion or collateral status, it is reasonable to minimize the time of transfer to maximize the possible role of ET. Therefore, these findings will apply to a large population.
This study has several limitations, beyond being a single center, retrospective analysis. The hub in this study is a large academic medical center in a metropolitan area, treating predominantly medically-insured white patients; this may limit generalizability, though there is inherent universality in the impact of delays and protocols to minimize them. Further, thrombectomy technology evolved during the study period, with stentrievers utilized since June of 2012. However, small numbers of patients before this timepoint limit the impact of this on our findings, and thrombectomy technique is independent of transfer metrics. Our established protocol and our data support that the majority of transfers were for ET evaluation, but we cannot exclude the possibility that a handful of patients may have been transferred for other reasons (consideration of hemicraniectomy, care of postthrombolysis complications, or other workup). Finally, the 2013 and 2015 ET trials were published during the study period, and we cannot exclude that they may have impacted decisions about transfer and management of patients with LVO. A recent analysis has shown that there has been a national increase in ET since 2015 trials. 29 Strengths of this study include the large sample size of patients, detailed information about transfer conditions, and the novel perspective of examining transfer time from initiation of telestroke consult.
Conclusions
This study identifies that longer transfer time is associated with decreased likelihood of undergoing ET, with a 44% chance of ET if transfer time is 60 minutes, but with a 1% decrease in the likelihood of ET with every subsequent passing minute. Nocturnal transfers were associated with greatest transfer delay, presenting a clear target for system based interventions. An algorithm to calculate target transfer times was used to provide data customizable to each individual center for the entire process of transfer and may aid quality metric calculations in future work. Refining system-wide transfer protocols will offer treatment access for more LVO patients and represents a frontier to explore with future studies.
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